STOCK TITAN

Vanguard disaggregates holdings — Harrow Inc (HROW) reports 0 shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Harrow Inc: Amendment No. 1 to a Schedule 13G/A was filed reporting that The Vanguard Group beneficially owns 0 shares of Harrow Inc common stock after an internal realignment effective January 12, 2026.

The filing explains that certain Vanguard subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538 (January 12, 1998). The statement is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard’s amendment documents internal disaggregation and shows no beneficial ownership in Harrow Inc.

The filing states The Vanguard Group now reports certain subsidiaries separately after an internal realignment on January 12, 2026, and reports 0 shares beneficially owned of common stock.

This is an administrative disclosure of ownership reporting structure under SEC Release No. 34-39538; cash‑flow treatment and any prior holdings are not detailed in the excerpt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does the Harrow Inc (HROW) 13G/A amendment say about Vanguard's holdings?

It states that The Vanguard Group reports 0 shares of Harrow Inc common stock following internal realignment. The filing explains subsidiaries now report separately in reliance on SEC Release No. 34-39538, effective January 12, 2026.

Why did The Vanguard Group change its reporting for Harrow Inc (HROW)?

Because of an internal realignment within The Vanguard Group, subsidiaries and business divisions will report beneficial ownership separately. The filing cites reliance on SEC Release No. 34-39538 (January 12, 1998) as the procedural basis.

Does the amendment show any shares retained or sold by Vanguard for HROW?

No; the amendment reports 0 shares beneficially owned and lists zero voting and dispositive powers. The filing does not describe prior transactions, sales, or proceeds in the provided excerpt.

Who signed the Harrow Inc (HROW) Schedule 13G/A amendment for Vanguard?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, and is dated 03/27/2026. The signature certifies the statements in the filing as presented.

Does this filing change Harrow Inc’s outstanding shares or operations?

No; the filing only addresses beneficial ownership reporting by The Vanguard Group and its subsidiaries. It does not state any changes to Harrow Inc’s outstanding shares, operations, or corporate actions.
Harrow Health

:HROWL

View HROWL Stock Overview

HROWL Rankings

HROWL Latest SEC Filings

HROWL Stock Data